Stocks and Investing
Stocks and Investing
Thu, November 9, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mason Carrico Upgraded (CDNA) to Buy and Held Target at $10 on, Nov 9th, 2023
Mason Carrico of Stephens & Co., Upgraded "CareDx, Inc" (CDNA) to Buy and Held Target at $10 on, Nov 9th, 2023.
Mason has made no other calls on CDNA in the last 4 months.
There are 2 other peers that have a rating on CDNA. Out of the 2 peers that are also analyzing CDNA, 1 agrees with Mason's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Yi Chen of "HC Wainwright & Co." Reiterated at Hold on, Wednesday, August 9th, 2023
This is the rating of the analyst that currently disagrees with Mason
- Andrew Cooper of "Raymond James" Upgraded from Hold to Buy and Held Target at $12 on, Tuesday, August 15th, 2023
Contributing Sources